
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), IQVIA Holdings Inc (NYSE:IQV), Agilent Technologies Inc (NYSE:A) and Waters Corp (NYSE:WAT).
Nautilus Biotechnology has a consensus price target of $2.92.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $0.929299 last updated September 8, 2026 at 2:34 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.